Oragenics, Inc. (AMEX:OGEN) went up by 6.62% from its latest closing price compared to the recent 1-year high of $2.09. The company’s stock price has collected 17.40% of gains in the last five trading sessions. Press Release reported on 09/11/20 that Oragenics Inc. to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference
Is It Worth Investing in Oragenics, Inc. (AMEX :OGEN) Right Now?
Plus, the 36-month beta value for OGEN is at 0.51. Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Oragenics, Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $2.50, which is -$0.68 below the current price. OGEN currently public float of 49.73M and currently shorts hold a 4.71% ratio of that float. Today, the average trading volume of OGEN was 8.51M shares.
OGEN’s Market Performance
OGEN stocks went up by 17.40% for the week, with a monthly drop of -30.82% and a quarterly performance of 23.95%, while its annual performance rate touched 20.51%. The volatility ratio for the week stands at 11.62% while the volatility levels for the past 30 days are set at 10.40% for Oragenics, Inc.. The simple moving average for the period of the last 20 days is -10.29% for OGEN stocks with a simple moving average of 5.20% for the last 200 days.
OGEN Trading at -28.51% from the 50-Day Moving Average
After a stumble in the market that brought OGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -67.56% of loss for the given period.
Volatility was left at 10.40%, however, over the last 30 days, the volatility rate increased by 11.62%, as shares sank -25.31% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.71% lower at present.
During the last 5 trading sessions, OGEN rose by +17.40%, which changed the moving average for the period of 200-days by +13.00% in comparison to the 20-day moving average, which settled at $0.7443. In addition, Oragenics, Inc. saw 29.64% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at OGEN starting from KOSKI ROBERT C, who sold 100,000 shares at the price of $0.53 back on Dec 30. After this action, KOSKI ROBERT C now owns 1,086,483 shares of Oragenics, Inc., valued at $52,610 using the latest closing price.
KOSKI ROBERT C, the Director of Oragenics, Inc., sold 100,000 shares at $0.52 during a trade that took place back on Dec 27, which means that KOSKI ROBERT C is holding 1,186,483 shares at $51,670 based on the most recent closing price.
Stock Fundamentals for OGEN
The total capital return value is set at -80.98, while invested capital returns managed to touch -80.27. Equity return is now at value -308.40, with -143.20 for asset returns.
Based on Oragenics, Inc. (OGEN), the company’s capital structure generated 5.69 points at debt to equity in total, while total debt to capital is 5.38. Total debt to assets is 4.96, with long-term debt to equity ratio resting at -2,175.23. Finally, the long-term debt to capital ratio is 6.26.